about
Obesity and osteoarthritis: more complex than predicted!Glycation of nail proteins: from basic biochemical findings to a representative marker for diabetic glycation-associated target organ damageTissue elasticity and the ageing elastic fibre.Sonographic evaluation of the shoulder in asymptomatic elderly subjects with diabetes.In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption.Optimization of protein crosslinking formulations for the treatment of degenerative disc disease.Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone.Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species.Inhibitory effect of gold nanoparticles on the D-ribose glycation of bovine serum albumin.The evolving role of obesity in knee osteoarthritis.Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) BlockadeSelf-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular diseaseCommonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease.Advanced glycation end products: Key players in skin aging?Management of limited joint mobility in diabetic patients.Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.Potential biomarkers of ageing.Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Lysosomes in iron metabolism, ageing and apoptosis.Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging.A new dermocosmetic containing retinaldehyde, delta-tocopherol glucoside and glycylglycine oleamide for managing naturally aged skin: results from in vitro to clinical studies.Genome-wide association study identifies common loci influencing circulating glycated hemoglobin (HbA1c) levels in non-diabetic subjects: the Long Life Family Study (LLFS).The renal effects of blood glucose-lowering plant-derived extracts in diabetes mellitus--an overview.Occurrence of tendon pathologies in metabolic disorders.Diabetic foot and exercise therapy: step by step the role of rigid posture and biomechanics treatment.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.Achilles tendinopathy in elderly subjects with type II diabetes: the role of sport activities.Joint aging and chondrocyte cell death.Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide.Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy.Tuning a 96-well microtiter plate fluorescence-based assay to identify AGE inhibitors in crude plant extracts.The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study.Advanced glycation end products and bone loss during aging.Advanced glycation end products-induced chondrocyte apoptosis through mitochondrial dysfunction in cultured rabbit chondrocyte.Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice.Bone Formation is Affected by Matrix Advanced Glycation End Products (AGEs) In Vivo.Amyloid fibrils in neurodegenerative diseases: villains or heroes?Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation.
P2860
Q24675065-3F5F05A2-0E4F-4D52-A7B0-B45CBD434478Q28544417-1E279EB7-8851-4805-B3C8-CD83E355DC8AQ30478322-08B39B10-E6B6-49C9-9287-FA4300F24104Q33765206-863C0509-4DDF-4D3D-9545-40F155D48623Q33885263-E82D74F4-036F-496E-A0C8-F3C5B5CE65D4Q34183103-1693B802-2731-4504-8AFF-431B019CEEFCQ34776819-F382E613-F7C9-423C-ADFE-95460D2F032FQ35230044-21F12794-C08C-4692-8259-08DBB43740B5Q35261440-923FE0EB-E242-40EA-872B-67A2B5E4723FQ35487583-3989A051-5B2E-4996-AEB8-A4B0D25B5DDBQ35792902-DC2648E4-D7E9-4F4B-8DD4-8D3FB147E169Q35830269-6E6527B5-B9A7-404F-9981-1CD84CE244AEQ35880193-EF8CFAD2-EEBE-4DA9-B294-CD9B4A544A9FQ36362707-C7551309-CD6F-4144-8E5E-D29FF084CE4DQ36643573-1CE17FE1-F301-4452-B1B9-DBB53369FA07Q36851848-623C4C37-E744-4FBD-AB3D-C16A5058967AQ36915810-C3ACBE8E-4FFE-4C73-AD13-83E75BDA07EEQ37061417-5D0327B8-EE7F-4692-BEBE-2E9ABB484F90Q37072018-223C7F02-E952-47E6-BCDD-3171773FA4D0Q37079830-48E5014F-5D32-4352-83BA-FC53E0C1A296Q37570507-35702E52-60F3-4CD7-A042-6D4032CF94B4Q37629561-58AFE031-2298-4411-B753-EDA01E853A10Q37662651-4162D6FB-7A0F-48BC-A2FC-1C7F27A7F91EQ37683784-D9F0C43A-1F5C-4918-A51F-8B203CAD1A39Q38073742-E392C47B-115C-4BCE-A301-D706D5829E77Q38210156-81083032-E404-422A-8115-BFE0C7C5CF20Q38620860-D77A5BE7-3DCF-4DB3-BACF-0666BD3EEFFEQ38700889-A3E5CA49-838A-4AAC-9B9C-0A7220A0F35EQ40852401-AC9525F2-6439-40E7-B9F4-15E481065896Q41877821-97314D3F-6D90-4001-89C9-78337B0E16EFQ41915321-9E3CF2A6-61AC-4E3C-94FB-749EF362B5DFQ42756908-A5635BE8-8DB8-408D-9159-BB20B07634E3Q43743450-F0FF7D52-E56B-4147-AED2-D9F61B1A56C9Q44789248-8C50EECD-ECA5-4187-AAAC-085AE31F3A28Q46613220-C9F30C33-925A-47E0-83B5-9B558E828803Q46830048-FBB1599C-A293-45B2-B854-A5B18BAF8342Q46858525-797A8582-945B-4D72-8C3D-837FE247D8A7Q51311945-D0622FA9-4EE6-4CC3-82B0-EC8A61B45647Q51347009-7A2F24F3-1FBE-4EC9-AADD-7A6DC2B53BF3Q53306751-18C83F95-ECB3-481D-91A6-113AE5769AE3
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The AGE of the matrix: chemistry, consequence and cure.
@ast
The AGE of the matrix: chemistry, consequence and cure.
@en
type
label
The AGE of the matrix: chemistry, consequence and cure.
@ast
The AGE of the matrix: chemistry, consequence and cure.
@en
prefLabel
The AGE of the matrix: chemistry, consequence and cure.
@ast
The AGE of the matrix: chemistry, consequence and cure.
@en
P1476
The AGE of the matrix: chemistry, consequence and cure.
@en
P2093
Jeroen DeGroot
P304
P356
10.1016/J.COPH.2004.01.007
P577
2004-06-01T00:00:00Z